Peptides for Men: A Complete UK Guide

Men's interest in peptides typically centres around several key goals: optimising body composition, supporting recovery from sports injuries, managing age-related hormonal decline, addressing sexual health, and increasingly, managing weight.

The peptide landscape relevant to men is broad — from pharmaceutical GLP-1 agonists prescribed for weight management to research peptides studied for tissue repair and hormone optimisation. Understanding which peptides have genuine evidence, which are approved medications, and which remain experimental is crucial for making informed decisions.

This guide covers the most relevant peptide categories for men's health, with UK-specific regulatory and access information throughout.

Growth hormone secretagogues (CJC-1295, ipamorelin, GHRP-2, GHRP-6, MK-677) are among the most discussed peptides in men's health circles.

What They Do:

GH secretagogues stimulate the pituitary gland to release more growth hormone, which declines naturally with age (somatopause). Higher GH levels may support: - Reduced body fat (particularly visceral fat) - Improved lean muscle mass - Better recovery from exercise - Enhanced sleep quality (GH is released during deep sleep) - Improved skin elasticity and collagen production

The Evidence:

• •MK-677 (oral GH secretagogue) studies show increased GH and IGF-1 levels, modest lean mass gains (+1.5-2kg), and improved sleep quality in older adults
• •CJC-1295 Phase II trials demonstrated dose-dependent GH elevation
• •Ipamorelin studies show selective GH release without cortisol or prolactin elevation

UK Status:

GH secretagogues are NOT approved for human use by the MHRA. They are classified as research compounds. They are prohibited by WADA in competitive sport. Any use should only occur under qualified medical supervision.

Comparison with TRT:

Many men considering GH secretagogues are also interested in testosterone replacement therapy. These address different aspects of hormonal health — GH secretagogues target the GH/IGF-1 axis, while TRT addresses testosterone deficiency. They are not interchangeable. See our peptides vs TRT comparison for a detailed analysis.

For men interested in supporting testosterone production through peptide-based approaches, two compounds have received research attention:

Kisspeptin

Kisspeptin is a naturally occurring peptide that stimulates GnRH (gonadotropin-releasing hormone) release from the hypothalamus, which in turn triggers LH and FSH release from the pituitary, ultimately stimulating testosterone production.

• •Imperial College London (Professor Waljit Dhillo's group) has conducted significant kisspeptin research
• •Studies show acute testosterone elevation following kisspeptin administration
• •Importantly, kisspeptin preserves fertility — unlike TRT, which suppresses sperm production
• •Clinical trial data exists in hypogonadal men showing testosterone increases

Gonadorelin

Gonadorelin is a synthetic form of GnRH (the hormone the hypothalamus naturally produces): - Used diagnostically in the UK to test pituitary function - Some clinics use it alongside TRT to maintain testicular function and fertility - Available as a prescription medication in the UK (for diagnostic purposes)

UK Context:

Neither kisspeptin nor gonadorelin is currently prescribed for testosterone optimisation on the NHS. Some private clinics offer gonadorelin alongside TRT protocols. Kisspeptin remains primarily a research tool. For men with confirmed testosterone deficiency, NICE and BSSM guidelines recommend TRT as the evidence-based treatment.

Sports injuries are a common driver of men's interest in peptides. BPC-157 and TB-500 are the most researched compounds in this space.

BPC-157 (Body Protection Compound-157)

• •Extensively studied in animal models for tendon, ligament, and muscle healing
• •Shows accelerated healing in Achilles tendon transection, rotator cuff injury, and muscle crush injury models
• •May have neuroprotective effects relevant to concussion recovery
• •Oral form (BPC-157 Arginate) studied for gut healing
• •NOT approved for human use in the UK

TB-500 (Thymosin Beta-4 Fragment)

• •Promotes cell migration to injury sites
• •Used in veterinary medicine for equine tendon injuries
• •Phase II clinical trials for cardiac repair in humans
• •May support muscle flexibility and recovery
• •NOT approved for human use in the UK

Practical Reality:

While the preclinical evidence is promising, men should understand that: - No peptides are approved for injury treatment in the UK - Evidence-based rehabilitation (physiotherapy, graded exercise) remains the standard of care - Using research compounds for injury carries unknown risks - WADA prohibits these peptides in competitive sport

GLP-1 Agonists for Weight Management

GLP-1 agonists (semaglutide/Wegovy, tirzepatide/Mounjaro) are increasingly relevant for men's health: - Reduce visceral fat — the metabolically dangerous fat linked to cardiovascular disease, type 2 diabetes, and reduced testosterone - STEP and SURMOUNT trial data shows significant cardiovascular risk reduction - Weight loss often improves testosterone levels in overweight/obese men - Available on NHS prescription for eligible patients

Men should be aware of the lean mass loss concern — resistance training and adequate protein intake are essential. See our semaglutide muscle loss article for detailed guidance.

PT-141 (Bremelanotide) for Sexual Health

PT-141 is a melanocortin-4 receptor agonist studied for sexual dysfunction: - Works centrally (in the brain) rather than peripherally like PDE5 inhibitors (Viagra, Cialis) - FDA-approved in the US as Vyleesi® for female sexual dysfunction - Studied in men with erectile dysfunction, particularly those who don't respond to PDE5 inhibitors - Not currently approved for men in the UK - Some private clinics offer off-label access

Melanotan II

Often discussed for tanning and libido effects, Melanotan II carries significant safety concerns: - MHRA has issued multiple safety warnings against its use - Associated with nausea, flushing, blood pressure changes, and concerning mole changes - Not approved for any medical use - The risks outweigh any cosmetic benefits

What's Available on NHS: - Semaglutide (Wegovy) and tirzepatide (Mounjaro) for weight management (with eligibility criteria) - Testosterone replacement therapy for confirmed hypogonadism (specialist referral required) - Gonadorelin for diagnostic pituitary function testing

What's Available Privately: - GLP-1 agonists through private clinics (if not eligible for NHS) - TRT through private men's health clinics - Some clinics offer GH secretagogues and other peptides under medical supervision (regulatory grey area)

What Remains Research-Only: - BPC-157, TB-500, GHK-Cu - CJC-1295, ipamorelin, GHRP-2/6 - Kisspeptin - PT-141 (for men)

Key Recommendations:

1. Start with evidence-based options: If your goal is weight loss, explore NHS GLP-1 agonist access. If testosterone is a concern, get bloodwork and a formal diagnosis through your GP. 2. Optimise the basics first: Sleep, exercise, nutrition, and stress management profoundly affect hormone levels, body composition, and recovery — often more than any peptide. 3. Be cautious with research peptides: Unapproved compounds carry unknown risks. If you choose to explore them, do so under qualified medical supervision with appropriate monitoring. 4. Avoid Melanotan II: The MHRA warnings are clear. The risk-benefit ratio does not favour its use.

*This guide is for educational purposes only. Consult a qualified healthcare professional for personalised medical advice.*